These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8285144)

  • 1. The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.
    Hasinoff BB; Kala SV
    Agents Actions; 1993 May; 39(1-2):72-81. PubMed ID: 8285144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin.
    Hasinoff BB
    Agents Actions; 1989 Mar; 26(3-4):378-85. PubMed ID: 2544086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).
    Hasinoff BB
    Agents Actions; 1990 Mar; 29(3-4):374-81. PubMed ID: 2160191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hydrolysis activation of the doxorubicin cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).
    Hasinoff BB
    Drug Metab Dispos; 1990; 18(3):344-9. PubMed ID: 1974197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes.
    Buss JL; Hasinoff BB
    Agents Actions; 1993 Sep; 40(1-2):86-95. PubMed ID: 8147274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH-cytochrome-P450 reductase promotes hydroxyl radical production by the iron complex of ADR-925, the hydrolysis product of ICRF-187 (dexrazoxane).
    Hasinoff BB
    Free Radic Res; 1995 Apr; 22(4):319-25. PubMed ID: 7633562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of the hydrolysis-activation of the cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane.
    Hasinoff BB
    J Pharm Sci; 1994 Jan; 83(1):64-7. PubMed ID: 8138912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron complexes of the cardioprotective agent dexrazoxane (ICRF-187) and its desmethyl derivative, ICRF-154: solid state structure, solution thermodynamics, and DNA cleavage activity.
    Diop NK; Vitellaro LK; Arnold P; Shang M; Marusak RA
    J Inorg Biochem; 2000 Feb; 78(3):209-16. PubMed ID: 10805177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals.
    Malisza KL; Hasinoff BB
    Arch Biochem Biophys; 1995 Feb; 316(2):680-8. PubMed ID: 7864623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enzymatic hydrolysis-activation of the adriamycin cardioprotective agent (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane.
    Hasinoff BB; Reinders FX; Clark V
    Drug Metab Dispos; 1991; 19(1):74-80. PubMed ID: 1673425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.
    Thomas C; Vile GF; Winterbourn CC
    Biochem Pharmacol; 1993 May; 45(10):1967-72. PubMed ID: 8390256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of dexrazoxane and analogues.
    Hasinoff BB
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):3-9. PubMed ID: 9768817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925.
    Schroeder PE; Hasinoff BB
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):509-13. PubMed ID: 12451479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroorotase catalyzes the ring opening of the hydrolysis intermediates of the cardioprotective drug dexrazoxane (ICRF-187).
    Schroeder PE; Davidson JN; Hasinoff BB
    Drug Metab Dispos; 2002 Dec; 30(12):1431-5. PubMed ID: 12433815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferrous ion strongly promotes the ring opening of the hydrolysis intermediates of the antioxidant cardioprotective agent dexrazoxane (ICRF-187).
    Buss JL; Hasinoff BB
    Arch Biochem Biophys; 1995 Feb; 317(1):121-7. PubMed ID: 7872773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the cardioprotective drug dexrazoxane and one of its metabolites by isolated rat myocytes, hepatocytes, and blood.
    Schroeder PE; Wang GQ; Burczynski FJ; Hasinoff BB
    Drug Metab Dispos; 2005 Jun; 33(6):719-25. PubMed ID: 15764716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the one-ring open metabolites of the cardioprotective drug dexrazoxane to its active metal-chelating form in the rat.
    Schroeder PE; Hasinoff BB
    Drug Metab Dispos; 2005 Sep; 33(9):1367-72. PubMed ID: 15980099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic ring-opening reactions of the chiral cardioprotective agent (+) (S)-ICRF-187 and its (-) (R)-enantiomer ICRF-186 by dihydropyrimidine amidohydrolase.
    Hasinoff BB
    Drug Metab Dispos; 1993; 21(5):883-8. PubMed ID: 7902252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyl radical production by the iron complex of the hydrolysis product of the antioxidant cardioprotective agent ICRF-187 (dexrazoxane).
    Malisza KL; Hasinoff BB
    Redox Rep; 1996 Feb; 2(1):69-73. PubMed ID: 27414516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin.
    Vile GF; Winterbourn CC
    Cancer Res; 1990 Apr; 50(8):2307-10. PubMed ID: 2156615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.